IP Library Granted Patent US 7,033,795
Granted Patent B2
US 7,033,795 · App. 10/304,617 · Granted Apr 25, 2006

FabK variant

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,033,795
App. No.
10/304,617
Granted
Apr 25, 2006
Kind
B2
Abstract

The invention provides FabK polypeptides and polynucleotides encoding FabK polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are preferred methods for utilizing FabK polypeptides and polynucleotides as diagnostic reagents and in diagnostic assays to screen for microbial infections in organisms and infestations in materials.

Claims (13)

1. An isolated polynucleotide comprising a nucleotide sequence encoding the polypeptide of SEQ ID NO: 2.

2. The isolated polynucleotide of claim 1 , further comprising a transcriptional regulatory sequence operably linked to said polynucleotide sequence.

3. The isolated polynucleotide of claim 1 , wherein said polypeptide is fused to a heterologous amino acid sequence.

4. An isolated vector comprising the isolated polynucleotide sequence of claim 1 .

5. An isolated host cell comprising the vector of claim 4 .

6. The host cell of claim 5 , wherein said host cell is prokaryotic or eukaryotic.

7. The host cell of claim 6 , which is a prokaryotic cell.

8. The host cell of claim 6 , which is a eukaryotic cell.

9. The isolated polynucleotide of claim 1 , consisting of a nucleotide sequence encoding the polypeptide of SEQ ID NO: 2.

10. The isolated polynucleotide of claim 1 , comprising the polynucleotide of SEQ ID NO: 1.

11. The isolated polynucleotide of claim 10 , consisting of the polynucleotide of SEQ ID NO: 1.

12. The prokaryotic cell of claim 7 , which is an isolated bacterial cell.

13. The eukaryotic cell of claim 8 , which is an isolated mammalian cell.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2014
From: DEBIOPHARM DIAGNOSTICS SA
To: DEBIOPHARM INTERNATIONAL SA
Reel/Frame 032776/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2014
From: AFFINIUM PHARMACEUTICALS, INC.
To: DEBIOPHARM DIAGNOSTICS SA; DEBIOPHARM INTERNATIONAL SA
Reel/Frame 032355/0132 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2003
From: SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE; SMITHKLINE BEECHAM P.L.C.
To: AFFINIUM PHARMACEUTICALS, INC.
Reel/Frame 013582/0808 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2003
From: SMITHKLINE BEECHAM CORPORATION D/B/A GLAXOSMITHKLINE
To: AFFINIUM PHARMACEUTICALS, INC.
Reel/Frame 013426/0471 →